Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Battalion Oil
BATL
$31.9M
| $383K | ﹤0.01% |
20,600
+3,900
| +23% | +$62.3K |
|
3352
Bogota Financial
BSBK
$116M
| $383K | ﹤0.01% |
35,736
-2,264
| -6% | -$23.3K |
|
3353
Urban One Class A
UONE
$22.8M
| $383K | ﹤0.01% |
6,120
+980
| +19% | +$52.6K |
|
|
BRG
3354
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $383K | ﹤0.01% |
+14,400
| New | +$382K |
|
3355
Alset
AEI
$39.7M
| $382K | ﹤0.01% |
41,531
-151,384
| -78% | -$1.23M |
|
|
AIOS
3356
AIOS Tech
AIOS
$38.4M
| $381K | ﹤0.01% |
1,947
+1,328
| +215% | +$361K |
|
3357
Columbia Sportswear
COLM
$3.04B
| $380K | ﹤0.01% |
4,200
-105,302
| -96% | -$9.74M |
|
3358
Stock Yards Bancorp
SYBT
$2.64B
| $380K | ﹤0.01% |
7,190
-3,300
| -31% | -$189K |
|
|
FRTX
3359
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $380K | ﹤0.01% |
31,546
-35,905
| -53% | -$388K |
|
|
SIOX
3360
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $380K | ﹤0.01% |
567,153
-86,547
| -13% | -$73.5K |
|
3361
Pulse Biosciences
PLSE
$2.43B
| $378K | ﹤0.01% |
+77,824
| New | +$637K |
|
3362
Vanguard FTSE Pacific ETF
VPL
$8.08B
| $378K | ﹤0.01% |
5,100
-8,100
| -61% | -$605K |
|
3363
Harley-Davidson
HOG
$2.58B
| $374K | ﹤0.01% |
9,500
-1,110,100
| -99% | -$42.8M |
|
3364
Immuneering
IMRX
$267M
| $373K | ﹤0.01% |
+57,600
| New | +$553K |
|
|
RPC
3365
Ridgepost Capital
RPC
$949M
| $373K | ﹤0.01% |
30,800
+6,900
| +29% | +$85.8K |
|
3366
Mid Penn Bancorp
MPB
$971M
| $369K | ﹤0.01% |
+13,769
| New | +$400K |
|
3367
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.14B
| $369K | ﹤0.01% |
+14,300
| New | +$384K |
|
|
CYT
3368
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $369K | ﹤0.01% |
97,800
+71,600
| +273% | +$408K |
|
3369
Schwab Fundamental International Small Company Index ETF
FNDC
$3.05B
| $368K | ﹤0.01% |
+10,400
| New | +$374K |
|
3370
Rallybio
RLYB
$84.5M
| $368K | ﹤0.01% |
+6,589
| New | +$545K |
|
3371
Interface
TILE
$1.99B
| $367K | ﹤0.01% |
27,041
-83,837
| -76% | -$1.16M |
|
3372
WPP
WPP
$4.36B
| $367K | ﹤0.01% |
+5,600
| New | +$417K |
|
3373
Arena Group
AREN
$57.1M
| $365K | ﹤0.01% |
+33,700
| New | +$300K |
|
3374
Envista
NVST
$4.44B
| $365K | ﹤0.01% |
7,500
-157,900
| -95% | -$7.28M |
|
3375
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.75B
| $365K | ﹤0.01% |
3,400
+100
| +3% | +$10.6K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.